Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.

Author: HoffmannV, KragballeK, NordinP, OrtonneJ P, SegaertS, TanJ

Paper Details 
Original Abstract of the Article :
BACKGROUND: Current topical therapies for scalp psoriasis are difficult or unpleasant to apply, resulting in decreased adherence and efficacy. OBJECTIVES: To compare the efficacy and safety of once-daily treatment with a combination of calcipotriol 50 microg g(-1) plus betamethasone 0.5 mg g(-1) (a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1365-2133.2009.09116.x

データ提供:米国国立医学図書館(NLM)

Calcipotriol Plus Betamethasone for Scalp Psoriasis: A Comparative Study

The treatment of scalp psoriasis can be a tricky endeavor, often involving therapies that are difficult to apply or uncomfortable for the patient. This study aims to address this challenge by comparing the efficacy and safety of two topical treatments: calcipotriol plus betamethasone dipropionate scalp formulation and calcipotriol scalp solution. The researchers employed a randomized controlled trial, a robust research method that allows for direct comparison of treatment outcomes.

Superior Efficacy of Combined Therapy

The results of this study demonstrate the superiority of the combined therapy of calcipotriol plus betamethasone dipropionate compared to calcipotriol alone. The study found that a significantly greater proportion of patients treated with the combined therapy achieved 'clear' or 'minimal' disease severity at week 8. Furthermore, the combined therapy showed more rapid improvement, and patients experienced fewer adverse events.

Improving Scalp Psoriasis Management

This research provides valuable information for dermatologists and their patients struggling with scalp psoriasis. The findings suggest that the combined therapy of calcipotriol plus betamethasone dipropionate could be a more effective and well-tolerated option for treating scalp psoriasis. This could lead to improved treatment outcomes and enhanced quality of life for patients. It's like finding a refreshing oasis in the desert of scalp psoriasis treatment options!

Dr.Camel's Conclusion

This research, like a cool breeze in the desert, offers a refreshing perspective on scalp psoriasis treatment. The findings suggest that the combined therapy of calcipotriol plus betamethasone dipropionate is a promising option for achieving clearer skin and a better quality of life for patients. Remember, even the most challenging conditions, like scalp psoriasis, can be managed effectively with the right approach.

Date :
  1. Date Completed 2009-09-23
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

19416259

DOI: Digital Object Identifier

10.1111/j.1365-2133.2009.09116.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.